Global Renal Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: G71076B32C5FEN
QYResearch

Abstracts

Renal Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Renal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

• Mylan
• Roche Holding
• Endo International
• Bausch Health Companies
• Apotex
• Cardinal Health
• Fresenius
• Dava Pharmaceuticals

Market segment by Type, the product can be split into

• Oral
• Injections

Market segment by Application, split into

• Hospital Pharmacy
• Retail Pharmacies
• Drug Stores
• Online Pharmacy
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Renal Drugs Revenue
1.4 Market by Type
  1.4.1 Global Renal Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Injections
1.5 Market by Application
  1.5.1 Global Renal Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Retail Pharmacies
  1.5.4 Drug Stores
  1.5.5 Online Pharmacy
  1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Renal Drugs Market Perspective (2015-2026)
2.2 Global Renal Drugs Growth Trends by Regions
  2.2.1 Renal Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Renal Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Renal Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Renal Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Renal Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Renal Drugs Players by Market Size
  3.1.1 Global Top Renal Drugs Players by Revenue (2015-2020)
  3.1.2 Global Renal Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Renal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Renal Drugs Market Concentration Ratio
  3.2.1 Global Renal Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Renal Drugs Revenue in 2019
3.3 Renal Drugs Key Players Head office and Area Served
3.4 Key Players Renal Drugs Product Solution and Service
3.5 Date of Enter into Renal Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Renal Drugs Historic Market Size by Type (2015-2020)
4.2 Global Renal Drugs Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Renal Drugs Market Size by Application (2015-2020)
5.2 Global Renal Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Renal Drugs Market Size (2015-2020)
6.2 Renal Drugs Key Players in North America (2019-2020)
6.3 North America Renal Drugs Market Size by Type (2015-2020)
6.4 North America Renal Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Renal Drugs Market Size (2015-2020)
7.2 Renal Drugs Key Players in Europe (2019-2020)
7.3 Europe Renal Drugs Market Size by Type (2015-2020)
7.4 Europe Renal Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Renal Drugs Market Size (2015-2020)
8.2 Renal Drugs Key Players in China (2019-2020)
8.3 China Renal Drugs Market Size by Type (2015-2020)
8.4 China Renal Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Renal Drugs Market Size (2015-2020)
9.2 Renal Drugs Key Players in Japan (2019-2020)
9.3 Japan Renal Drugs Market Size by Type (2015-2020)
9.4 Japan Renal Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Renal Drugs Market Size (2015-2020)
10.2 Renal Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Renal Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Renal Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Renal Drugs Market Size (2015-2020)
11.2 Renal Drugs Key Players in India (2019-2020)
11.3 India Renal Drugs Market Size by Type (2015-2020)
11.4 India Renal Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Renal Drugs Market Size (2015-2020)
12.2 Renal Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Renal Drugs Market Size by Type (2015-2020)
12.4 Central & South America Renal Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Mylan
  13.1.1 Mylan Company Details
  13.1.2 Mylan Business Overview
  13.1.3 Mylan Renal Drugs Introduction
  13.1.4 Mylan Revenue in Renal Drugs Business (2015-2020))
  13.1.5 Mylan Recent Development
13.2 Roche Holding
  13.2.1 Roche Holding Company Details
  13.2.2 Roche Holding Business Overview
  13.2.3 Roche Holding Renal Drugs Introduction
  13.2.4 Roche Holding Revenue in Renal Drugs Business (2015-2020)
  13.2.5 Roche Holding Recent Development
13.3 Endo International
  13.3.1 Endo International Company Details
  13.3.2 Endo International Business Overview
  13.3.3 Endo International Renal Drugs Introduction
  13.3.4 Endo International Revenue in Renal Drugs Business (2015-2020)
  13.3.5 Endo International Recent Development
13.4 Bausch Health Companies
  13.4.1 Bausch Health Companies Company Details
  13.4.2 Bausch Health Companies Business Overview
  13.4.3 Bausch Health Companies Renal Drugs Introduction
  13.4.4 Bausch Health Companies Revenue in Renal Drugs Business (2015-2020)
  13.4.5 Bausch Health Companies Recent Development
13.5 Apotex
  13.5.1 Apotex Company Details
  13.5.2 Apotex Business Overview
  13.5.3 Apotex Renal Drugs Introduction
  13.5.4 Apotex Revenue in Renal Drugs Business (2015-2020)
  13.5.5 Apotex Recent Development
13.6 Cardinal Health
  13.6.1 Cardinal Health Company Details
  13.6.2 Cardinal Health Business Overview
  13.6.3 Cardinal Health Renal Drugs Introduction
  13.6.4 Cardinal Health Revenue in Renal Drugs Business (2015-2020)
  13.6.5 Cardinal Health Recent Development
13.7 Fresenius
  13.7.1 Fresenius Company Details
  13.7.2 Fresenius Business Overview
  13.7.3 Fresenius Renal Drugs Introduction
  13.7.4 Fresenius Revenue in Renal Drugs Business (2015-2020)
  13.7.5 Fresenius Recent Development
13.8 Dava Pharmaceuticals
  13.8.1 Dava Pharmaceuticals Company Details
  13.8.2 Dava Pharmaceuticals Business Overview
  13.8.3 Dava Pharmaceuticals Renal Drugs Introduction
  13.8.4 Dava Pharmaceuticals Revenue in Renal Drugs Business (2015-2020)
  13.8.5 Dava Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Renal Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Renal Drugs Revenue
Table 3. Ranking of Global Top Renal Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Renal Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injections
Table 7. Global Renal Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Renal Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Renal Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Renal Drugs Market Share by Regions (2015-2020)
Table 11. Global Renal Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Renal Drugs Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Renal Drugs Market Growth Strategy
Table 17. Main Points Interviewed from Key Renal Drugs Players
Table 18. Global Renal Drugs Revenue by Players (2015-2020) (Million US$)
Table 19. Global Renal Drugs Market Share by Players (2015-2020)
Table 20. Global Top Renal Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Drugs as of 2019)
Table 21. Global Renal Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Renal Drugs Product Solution and Service
Table 24. Date of Enter into Renal Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 27. Global Renal Drugs Market Size Share by Type (2015-2020)
Table 28. Global Renal Drugs Revenue Market Share by Type (2021-2026)
Table 29. Global Renal Drugs Market Size Share by Application (2015-2020)
Table 30. Global Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 31. Global Renal Drugs Market Size Share by Application (2021-2026)
Table 32. North America Key Players Renal Drugs Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Renal Drugs Market Share (2019-2020)
Table 34. North America Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. North America Renal Drugs Market Share by Type (2015-2020)
Table 36. North America Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. North America Renal Drugs Market Share by Application (2015-2020)
Table 38. Europe Key Players Renal Drugs Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Renal Drugs Market Share (2019-2020)
Table 40. Europe Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Renal Drugs Market Share by Type (2015-2020)
Table 42. Europe Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Renal Drugs Market Share by Application (2015-2020)
Table 44. China Key Players Renal Drugs Revenue (2019-2020) (Million US$)
Table 45. China Key Players Renal Drugs Market Share (2019-2020)
Table 46. China Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. China Renal Drugs Market Share by Type (2015-2020)
Table 48. China Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. China Renal Drugs Market Share by Application (2015-2020)
Table 50. Japan Key Players Renal Drugs Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Renal Drugs Market Share (2019-2020)
Table 52. Japan Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Renal Drugs Market Share by Type (2015-2020)
Table 54. Japan Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Renal Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Renal Drugs Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Renal Drugs Market Share (2019-2020)
Table 58. Southeast Asia Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Renal Drugs Market Share by Type (2015-2020)
Table 60. Southeast Asia Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Renal Drugs Market Share by Application (2015-2020)
Table 62. India Key Players Renal Drugs Revenue (2019-2020) (Million US$)
Table 63. India Key Players Renal Drugs Market Share (2019-2020)
Table 64. India Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. India Renal Drugs Market Share by Type (2015-2020)
Table 66. India Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. India Renal Drugs Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Renal Drugs Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Renal Drugs Market Share (2019-2020)
Table 70. Central & South America Renal Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Renal Drugs Market Share by Type (2015-2020)
Table 72. Central & South America Renal Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Renal Drugs Market Share by Application (2015-2020)
Table 74. Mylan Company Details
Table 75. Mylan Business Overview
Table 76. Mylan Product
Table 77. Mylan Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 78. Mylan Recent Development
Table 79. Roche Holding Company Details
Table 80. Roche Holding Business Overview
Table 81. Roche Holding Product
Table 82. Roche Holding Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 83. Roche Holding Recent Development
Table 84. Endo International Company Details
Table 85. Endo International Business Overview
Table 86. Endo International Product
Table 87. Endo International Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 88. Endo International Recent Development
Table 89. Bausch Health Companies Company Details
Table 90. Bausch Health Companies Business Overview
Table 91. Bausch Health Companies Product
Table 92. Bausch Health Companies Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 93. Bausch Health Companies Recent Development
Table 94. Apotex Company Details
Table 95. Apotex Business Overview
Table 96. Apotex Product
Table 97. Apotex Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 98. Apotex Recent Development
Table 99. Cardinal Health Company Details
Table 100. Cardinal Health Business Overview
Table 101. Cardinal Health Product
Table 102. Cardinal Health Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 103. Cardinal Health Recent Development
Table 104. Fresenius Company Details
Table 105. Fresenius Business Overview
Table 106. Fresenius Product
Table 107. Fresenius Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 108. Fresenius Recent Development
Table 109. Dava Pharmaceuticals Business Overview
Table 110. Dava Pharmaceuticals Product
Table 111. Dava Pharmaceuticals Company Details
Table 112. Dava Pharmaceuticals Revenue in Renal Drugs Business (2015-2020) (Million US$)
Table 113. Dava Pharmaceuticals Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Renal Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injections Features
Figure 4. Global Renal Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Renal Drugs Report Years Considered
Figure 11. Global Renal Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Renal Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Renal Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Renal Drugs Market Share by Players in 2019
Figure 16. Global Top Renal Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Renal Drugs Revenue in 2019
Figure 18. North America Renal Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Renal Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Renal Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Renal Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Renal Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Renal Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Renal Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed